1. ASPI's subsidiary QLE submitted a draft IPO registration to the SEC. 2. Details on share number and pricing were not disclosed yet. 3. IPO is subject to SEC review and market conditions. 4. QLE focuses on producing isotopes for healthcare and technology. 5. ASPI aims to enhance isotope production for nuclear energy.
The IPO submission indicates growth potential for the company and reflects confidence in its future. Historically, successful IPOs in the sector often lead to stock price increases for parent companies, such as when companies like Tesla saw stock price boosts following announcements related to their spin-offs and IPOs.
The draft IPO signals strategic expansion and an opportunity for capital raising, factors that could drive ASPI's market position and revenue growth significantly.
The IPO process is extensive, with potential effects manifesting over time as market conditions evolve. Long-term viability in the isotope market could significantly enhance ASPI’s valuation after successful fundraising.
WASHINGTON, Nov. 12, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ:ASPI) today announced that its wholly-owned subsidiary, Quantum Leap Energy LLC ("QLE"), has confidentially submitted a draft registration statement on Form S-1 to the Securities and Exchange Commission (the "SEC") relating to the proposed initial public offering of QLE's Class A common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. The proposed initial public offering remains subject to the completion of the SEC review process as well as market and other conditions.
This press release is being issued pursuant to, and in accordance with, Rule 135 promulgated under the Securities Act of 1933, as amended (the "Securities Act"). This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities. Any offers, solicitations of offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act.
About ASP Isotopes Inc.
ASP Isotopes Inc. is a development stage advanced materials company dedicated to the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process ("ASP technology"). The Company's initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. The Company also plans to enrich isotopes for the nuclear energy sector using Quantum Enrichment technology that the Company is developing. The Company has isotope enrichment facilities in Pretoria, South Africa, dedicated to the enrichment of isotopes of elements with a low atomic mass (light isotopes).
Contacts
Jason Assad– Investor relations
Email: JAssad@ASPIsotopes.com
